Nuriulú-Escobar PL, Leal-Alvarado TM, Puente-Barragán A

Idioma: Inglés [English version]
Referencias bibliográficas: 7
Paginas: s32-34
Archivo PDF: 117.46 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019; 105 (16): 1273-1278. doi: 10.1136/heartjnl-2018-313453.

2. Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75 (20): 2602-2618. doi: 10.1016/j.jacc.2020.03.060.

3. Groenhof TKJ, Zoet GA, Franx A, Gansevoort RT, Bots ML, Groen H et al. Trajectory of cardiovascular risk factors after hypertensive disorders of pregnancy. Hypertension. 2019; 73 (1): 171-178. doi: 10.1161/HYPERTENSIONAHA.118.11726.

4. Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 76 (14): 1690-1702. doi: 10.1016/j.jacc.2020.08.014.

5. Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertension Res. 2022; 45 (8):1298-1309. doi: 10.1038/s41440-022-00965-6.

6. Del-Sueldo MA, Mendonca-Rivera MA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M et al. Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women. Arch Cardiol Mex. 2022; 92 (Supl 2): 1-68. doi: 10.24875/ACM.22000071.

7. Stuart JJ, Tanz LJ, Rimm EB, Spiegelman D, Missmer SA, Mukamal K J et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy. J Am Coll Cardiol. 2022; 79 (19): 1901-1913. doi: 10.1016/j.jacc.2022.03.335,